£74.87

Springer Novel therapeutic approaches for gastrointestinal malignancies (Diagnostics and Therapeutic Advances in GI Malignancies)

Price data checked 5 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 1 month ago.

£75 today · all-time low £74 (May 2026) · usually £76

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 86 days • 86 data points (No recent data available)

Historical
Generating forecast...
£76.23 £74.07 £74.54 £75.01 £75.49 £75.96 £76.43 01 March 2026 22 March 2026 12 April 2026 03 May 2026 25 May 2026

Price Distribution

Price distribution over 86 days • 3 price levels

Days at Price
Current Price
5 days 51 days · current 30 days 0 13 26 38 51 £74 £75 £76 Days at Price

Price Analysis

Most common price: £75 (51 days, 59.3%)

Price range: £74 - £76

Price levels: 3 different prices over 86 days

Description

This book provides an up-to-date overview of gastrointestinal malignancies, including prevention, early detection, intervention, and life-extending therapeutics. It also assesses various biomarkers used for diagnostics, prognostics and prediction of response to chemoresistance. Further, it discusses the latest trends in the use of small-molecule targeted therapies and immunotherapies as single agents or combination with other treatments. Since resistance to radiation and chemotherapy contribute to the high recurrence and poor survival rates, improving the outcome for GI malignancies is dependent on the introduction of new biomarkers and therapeutic agents. Lastly, the book systematically investigates novel theranostics approaches using nanotechnology for the detection, diagnosis, and personalized treatment of GI malignancies. From the Back Cover This book provides an up-to-date overview of gastrointestinal malignancies, including prevention, early detection, intervention, and life-extending therapeutics. It also assesses various biomarkers used for diagnostics, prognostics and prediction of response to chemoresistance. Further, it discusses the latest trends in the use of small-molecule targeted therapies and immunotherapies as single agents or combination with other treatments. Since resistance to radiation and chemotherapy contribute to the high recurrence and poor survival rates, improving the outcome for GI malignancies is dependent on the introduction of new biomarkers and therapeutic agents. Lastly, the book systematically investigates novel theranostics approaches using nanotechnology for the detection, diagnosis, and personalized treatment of GI malignancies. About the Author Dr. Nagaraju GP is a faculty member in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Nagaraju obtained his PhD, in Biotechnology, from Sri Venkateswara University in Tirupati, Andhra Pradesh, India. Dr. Nagaraju received his DSc from Berhampur University in Berhampur, Odisha, India. Dr. Nagaraju’s research focuses on translational projects related to gastrointestinal malignancies. He has published over 90 research papers in highly reputed International journals and has presented more than 50 abstracts at various national and international conferences. Dr, Nagaraju is author and editor of several published books . He serves as editorial board member of several internationally recognized academic journals. Dr. Nagaraju is an associate member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute. Dr. Nagaraju has received several international awards including FAACC. He also holds memberships with many international and national professional agencies. Dr. Sujatha Peela is a full-time Professor in the Department of Biotechnology, Dr.B.R.Ambedkar University, Srikakulam, Andhra Pradesh, INDIA. Dr. Peela received her Doctorate in Biotechnology from Andhra University, Visakhapatnam, INDIA. Furthermore, she pursued her postdoctoral fellowship from the University of Chicago, USA in the Department of Medicine. She has published 33 research papers in various highly reputed International journals and attended 84 national and international conferences. Dr. Peela has published 4 books at international level. She received many prestigious awards from many government agencies & NGOs. Currently, she is playing critical roles in the administration of the state & central including, Principal, for College of Science, Dean for Research Development & Foreign Relations, Faculty Chairperson, in Dr.B.R. Ambedkar University. She organized 16 national and international conferences at various platforms in the Biotechnology field. She has one patent TEMP/E-1/44893/2018-DEL in India. She has membership with many international and national professional agencies.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
03 October 2021
Listed Since
05 September 2021

Barcode

No barcode data available

Similar Products You Might Like

Molecular Targets and Strategies in Cancer Prevention
82% match

Molecular Targets and Strategies in Cancer Prevention

Springer

£107.33 25 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
81% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£71.91 25 May 2026
Current Applications for Overcoming Resistance to Targeted Therapies: 20 (Resistance to Targeted Anti-Cancer Therapeutics, 20)
81% match

Current Applications for Overcoming Resistance to Targeted Therapies: 20 (Resistance to Targeted Anti-Cancer Therapeutics, 20)

Springer

£75.68 25 May 2026
Nutraceuticals and Cancer
81% match

Nutraceuticals and Cancer

Springer

£113.76 25 May 2026
Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract: 908 (Advances in Experimental Medicine and Biology, 908)
81% match

Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract: 908 (Advances in Experimental Medicine and Biology, 908)

Springer

£108.92 29 May 2026
Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)
80% match

Nano-Oncologicals: New Targeting and Delivery Approaches (Advances in Delivery Science and Technology)

Springer

£114.71 21 May 2026
Molecular Pathogenesis of Colorectal Cancer
80% match

Molecular Pathogenesis of Colorectal Cancer

Springer

£107.98 28 May 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
80% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.64 24 May 2026
Next Generation Graphene Nanomaterials for Cancer Theranostic Applications
80% match

Next Generation Graphene Nanomaterials for Cancer Theranostic Applications

Springer

£100.08 26 May 2026
Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs
80% match

Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs

Springer

£77.90 18 May 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
80% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£74.87 24 May 2026
Colorectal Cancer: Prevention, Diagnosis and Treatment
80% match

Colorectal Cancer: Prevention, Diagnosis and Treatment

£55.55 24 May 2026
80% match

Nanotechnology in Brain Tumor Treatment: Unveiling Molecular Mechanisms and Pioneering Therapies

Academic Press

£137.99 22 May 2026
Precision Medicine in Oncology
80% match

Precision Medicine in Oncology

Wiley-Blackwell

£133.95 22 May 2026
Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)
80% match

Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)

Wiley

£110.02 20 May 2026
79% match

Molecular Mechanisms of Cancer Resistance: Emerging Technologies and Therapeutic Strategies (Novel approaches to overcome cancer resistance to conventional therapies)

Academic Press

£153.99 22 May 2026
Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)
79% match

Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)

Springer

£107.98 27 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
79% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 24 May 2026
Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs: Cell Signaling Pathways and microRNAs in Cancer Biology
79% match

Recent Trends in Cancer Biology: Spotlight on Signaling Cascades and microRNAs: Cell Signaling Pathways and microRNAs in Cancer Biology

Springer

£107.98 11 May 2026
Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies
79% match

Cellular Therapies for Cancer Treatment: Advancements in Drug Delivery Strategies

Academic Press

£141.99 30 May 2026
Spotlight on Familial and Hereditary Gastric Cancer
79% match

Spotlight on Familial and Hereditary Gastric Cancer

Springer

£113.09 26 May 2026
Pharmacotherapeutic Botanicals for Cancer Chemoprevention
79% match

Pharmacotherapeutic Botanicals for Cancer Chemoprevention

Springer

£100.08 30 May 2026
Resistance to Molecular Therapies for Hepatocellular Carcinoma: 13 (Resistance to Targeted Anti-Cancer Therapeutics)
79% match

Resistance to Molecular Therapies for Hepatocellular Carcinoma: 13 (Resistance to Targeted Anti-Cancer Therapeutics)

Springer

£107.27 28 May 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
78% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£107.98 29 May 2026